Table 2.
Clinical characteristics of patients included in the study.
| Patient ID | Age | Irradiation dose | Gender | Type of RT | Chemotherapy | Targeted therapy | Surgery | Histology |
|---|---|---|---|---|---|---|---|---|
| 1 | 60 | 50 | Female | Postoperative | – | – | + | Squamous cell carcinoma |
| 2 | 73 | 56 | Male | Postoperative | – | – | + | Myoepithelial carcinoma |
| 3 | 65 | 60 | Female | Postoperative | – | – | + | Squamous cell carcinoma |
| 4 | 71 | 60 | Female | Postoperative | – | – | + | Squamous cell carcinoma |
| 5 | 58 | 60 | Male | Postoperative | – | – | + | Squamous cell carcinoma |
| 6 | 41 | 60 | Female | Postoperative | + | – | + | Squamous cell carcinoma |
| 7 | 82 | 60 | Male | Postoperative | – | – | + | Neuroendocrine cancer |
| 8 | 51 | 60 | Female | Postoperative | + | – | + | Squamous cell carcinoma |
| 9 | 58 | 60 | Male | Postoperative | – | – | + | Squamous cell carcinoma |
| 10 | 82 | 60 | Male | Postoperative | – | – | + | Squamous cell carcinoma |
| 11 | 66 | 66 | Female | Postoperative | – | – | + | Adenocarcinoma |
| 12 | 73 | 66 | Female | Postoperative | – | – | + | Adenocarcinoma |
| 13 | 66 | 66 | Female | Postoperative | – | – | + | Myoepithelial carcinoma |
| 14 | 51 | 66 | Female | Postoperative | – | – | + | Squamous cell carcinoma |
| 15 | 65 | 66 | Female | Postoperative | – | – | + | Squamous cell carcinoma |
| 16 | 54 | 68 | Male | Primary | + | – | – | Squamous cell carcinoma |
| 17 | 75 | 68 | Male | Primary | – | – | – | Squamous cell carcinoma |
| 18 | 82 | 68 | Female | Primary | – | – | – | Squamous cell carcinoma |
| 19 | 61 | 68 | Male | Primary | + | – | – | Squamous cell carcinoma |
| 20 | 70 | 68 | Male | Primary | + | – | – | Squamous cell carcinoma |
| 21 | 58 | 68 | Male | Primary | + | – | – | Squamous cell carcinoma |
| 22 | 69 | 68 | Female | Primary | – | + | – | Squamous cell carcinoma |
| 23 | 67 | 68 | Male | Primary | + | – | – | Squamous cell carcinoma |
| 24 | 59 | 68 | Male | Primary | – | – | – | Squamous cell carcinoma |
| 25 | 53 | 68 | Male | Primary | + | – | – | Squamous cell carcinoma |
| 26 | 64 | 68 | Male | Primary | + | – | – | Squamous cell carcinoma |
| 27 | 57 | 68 | Male | Primary | + | – | – | Squamous cell carcinoma |
| 28 | 68 | 68 | Male | Primary | + | – | – | Squamous cell carcinoma |
| 29 | 63 | 70 | Female | Primary | + | – | – | Squamous cell carcinoma |